Kena Lin

Kena Lin

Auto-generated profile, based on publicly available information

Kena Lin

School of Public Health, Guangdong Medical University, Dongguan, Guangdong, China; Department of Cancer Prevention, Sun Yat-sen University Cancer Center, Guangzhou, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2023 in Virus Research
Verified
Journal Article
Open access
KLKena Lin
Kena Lin
ZZZhiwen Zeng
Zhiwen Zeng
XLXueqi Li
Xueqi Li
WCWenjie Chen
Wenjie Chen
DLDongfeng Lin
Dongfeng Lin
JDJinlin Du
Jinlin Du
Hypertension may increase the infection risk of multiple viruses. The evidence for the association between hypertension and Epstein-Barr virus (EBV) reactivation is still largely lacking. The study was based on the baseline information of a population-based prospective cohort from high-risk areas of nasopharyngeal carcinoma (NPC). Using two EBV reactivation classification criteria, we explored the relationship between hypertension and EBV reactivation through logistic regression models. We included a total of 12,159 subjects. Among them, 3,945 (32.45%) were EBV arbitrary seropositive, and 1,547 (12.72%) were EBV comprehensive seropositive. Hypertension was associated with an increased risk of EBV reactivation, with odds ratios (ORs) of 1.17 (95% CI = 1.08–1.27) for EBV arbitrary seropositive subjects and 1.16 (95% CI = 1.03–1.30) for EBV comprehensive seropositive subjects. Two types of antihypertensive drugs were associated with decreased risk of EBV reactivation: β-adrenergic receptor-blocking agents (β-blockers) (OR = 0.51, 95% CI = 0.42–0.61 for EBV arbitrary seropositive subjects; OR = 0.62, 95% CI = 0.47–0.81 for EBV comprehensive seropositive subjects) and angiotensin converting enzyme inhibitors (ACEIs) (OR = 0.61, 95% CI = 0.41–0.88 for EBV arbitrary seropositive subjects; OR = 0.58, 95% CI = 0.32–0.98 for EBV comprehensive seropositive subjects). Hypertension was associated with an increased risk of EBV reactivation in high-incidence areas of NPC. β-blockers and ACEIs reduce this risk, and thus might be used for NPC prevention in endemic areas.